IGFBP2 and COVID-19: Notably, the results showed that both BP2 and BP9 have IC50 values in the nM range, which are similar or even better to those reported for other SARS-CoV-2 blocking peptides, highlighting the potential of these BPs for the developing of a novel treatment strategy for COVID-19.